Eton Pharmaceuticals (ETON) was upgraded by Zacks Research from "hold" to "strong-buy".
Eton Pharmaceuticals (ETON) had its price target raised by HC Wainwright from $37.00 to $52.00. They now have a "buy" rating on the stock.
Eton Pharmaceuticals (ETON) had its price target raised by B. Riley Financial, Inc. from $26.00 to $31.00. They now have a "buy" rating on the stock.
Eton Pharmaceuticals (ETON) had its price target raised by Craig Hallum from $30.00 to $35.00. They now have a "buy" rating on the stock.
Eton Pharmaceuticals Inc (ETON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]